About The Study
Narcolepsy is a disorder characterized by persistent daytime sleepiness, often causing “sleep attacks” where patients experience a sudden, often inappropriate need to fall asleep.
Other symptoms of narcolepsy may include cataplexy, sleep paralysis, hallucinations and sleep walking, although few sufferers experience all symptoms.
It is thought that the symptoms of narcolepsy occur when you lose the ability to regulate your sleep-wake cycles, which causes the normal boundaries between sleeping and being awake to get blurred. This is caused when an autoimmune process in the brain damages a special group of neurons that helps increase wakefulness.
Until recently, therapy for narcolepsy consisted primarily of amphetamines, and related stimulants, to help increase alertness during the day.
This research study is testing the effectiveness of an investigational medication to activate the damaged neurons in the brain and reduce the symptoms of narcolepsy.
To qualify for this study you must:
- Be between 18 and 50 years of age
- Have a diagnosis of narcolepsy confirmed by a doctor
Qualified participants will be seen by a doctor and receive all study-related exams, care and medications at no cost. Compensation for time and travel may be available.